NCT00116116: DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy |
|
|
| Completed | 4 | 70 | US | efavirenz, stavudine extended release, lamivudine | Bristol-Myers Squibb | HIV Infections, AIDS | 06/05 | 06/05 | | |
NCT00055120: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections |
|
|
| Completed | 4 | 283 | US, RoW | Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, AIDS-Related Opportunistic Infections | 09/06 | 08/07 | | |
NCT00618176: Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort |
|
|
| Completed | 4 | 198 | RoW | Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP), Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP), Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP) | Peking Union Medical College, Ministry of Science and Technology of the People´s Republic of China | HIV Infections | 09/06 | | | |
